The recommended dosage for the treatment of ulcerative colitis in adults is 5mg per kg as an intravenous infusion over two hours, followed by an additional 5mg per kg infusion at two weeks and
six weeks after the first infusion, then every eight weeks thereafter. Clinical response is usually achieved within 14 weeks (ie, after three doses).
Remicade is not recommended for use in patients younger than 17 years.
Further information: Schering-Plough Ltd, Schering-Plough House, Shire Park, Welwyn Garden City, Herts, AL7 1TW. Tel: (01707) 363636.